Cigna (CI) and Humana (HUM) are in talks regarding a potential stock-and-cash merger deal that “would create a new powerhouse in the health-insurance industry,” people familiar with the matter told The Wall Street Journal’s Lauren Thomas, Anna Wilde Mathews and Laura Cooper. A combination of the managed-care providers could be finalized by the end of the year, assuming the talks don’t fall apart, the report added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CI:
- M & A News: Cigna (NYSE:CI) Plunges after Potential Humana Merger
- Foot Locker, Teamsters drop drug-benefit managers over costs, WSJ says
- Cigna price target raised to $351 from $345 at Deutsche Bank
- Cigna price target raised to $334 from $300 at Wells Fargo
- Cigna explores sale of Medicare Advantage business, Reuters reports